W.R. Berkley Corp’s AEON Biopharma AEON Stock Holding History

W.R. Berkley Corp’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-693	Closed	-$526K	–	215
2023 Q2	$526K	Hold	693	–	–	0.03%	201
2023 Q1	$506K	Sell	693 -1,003	-59%	-$728K	0.03%	206
2022 Q4	$1.23M	Hold	1,696	–	–	0.07%	212
2022 Q3	$1.2M	Buy	1,696 +1,348	+387%	+$955K	0.06%	318
2022 Q2	$246K	Hold	348	–	–	0.01%	512
2022 Q1	$245K	Hold	348	–	–	0.01%	522
2021 Q4	$244K	Hold	348	–	–	0.01%	512
2021 Q3	$244K	Buy	+348	New	+$243K	0.02%	399

Other funds holding AEON

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

W.R. Berkley Corp's AEON Position: Q3 2023 in Review

W.R. Berkley Corp sold out of AEON Biopharma (AEON) in Q3 2023, closing a stake of 693 shares — an estimated $526K sold.

W.R. Berkley Corp first reported a position in AEON in Q3 2021 and held it in 8 quarters. The position peaked at $1.23M in Q4 2022. 15 funds tracked by Wall St. Rank hold AEON as of Q3 2023.

W.R. Berkley Corp reported no remaining AEON Biopharma position as of Q3 2023 after selling out during the quarter.
W.R. Berkley Corp sold 693 AEON Biopharma shares in Q3 2023, an estimated $526K.
W.R. Berkley Corp first reported a position in AEON Biopharma in Q3 2021 and held it in 8 quarters.
W.R. Berkley Corp's AEON Biopharma position peaked at $1.23M in Q4 2022.
15 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2023.

Based on W.R. Berkley Corp's 13F filing for Q3 2023, filed 14 Nov 2023.